What Is Quality by Design and Why It Matters in MaltaUntitledBuilding Quality in, Not Testing It Out
Quality by Design (QbD) is a systematic, science-based approach to pharmaceutical product and process development that builds quality into a medicine from the design stage rather than testing it in at the end. This Quality by Design Training in Malta gives pharmaceutical, biopharmaceutical and API professionals a working command of the ICH Q8, Q9, Q10 and Q11 framework that regulators such as the FDA and EMA now expect in modern development submissions. Across Malta's generics and API manufacturing base, employers value people who can turn regulatory expectation into practice: defining the Quality Target Product Profile (QTPP), identifying Critical Quality Attributes (CQAs), running structured risk assessment and Design of Experiments (DoE), mapping a design space and building a robust control strategy. Delivered by Invensis Learning in live virtual, classroom and corporate formats, the one-day programme is practical from the first hour, with hands-on QbD tool exercises on realistic development scenarios. If you develop, test or submit pharmaceutical products, this training turns QbD from a compliance phrase into a repeatable way of working.










